<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Johnson HM</submitter><funding>NIDA NIH HHS</funding><funding>NCRR NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>NCI NIH HHS</funding><funding>Wellcome Trust</funding><pagination>e35332</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3322167</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(4)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>The mechanisms by which smoking cessation reduces cardiovascular disease risk are unclear. We evaluated longitudinal changes in carotid intima-media thickness among current smokers enrolled in a prospective, randomized smoking cessation clinical trial.&lt;h4>Methodology/principal findings&lt;/h4>Subjects were enrolled in a randomized, double-blind, placebo-controlled trial of 5 smoking cessation pharmacotherapies and underwent carotid ultrasonography with carotid intima-media thickness measurement. Subjects were classified as continuously abstinent (biochemically confirmed abstinence at 6 months, 1 year, and 3 years post-quit attempt), intermittently abstinent (reported smoking at one of the three time points), or smoked continuously (reported smoking at all three time points)</pubmed_abstract><journal>PloS one</journal><pubmed_title>Effects of smoking and cessation on subclinical arterial disease: a substudy of a randomized controlled trial.</pubmed_title><pmcid>PMC3322167</pmcid><funding_grant_id>K05 CA139871</funding_grant_id><funding_grant_id>T32 HL007936</funding_grant_id><funding_grant_id>T32 HL07936</funding_grant_id><funding_grant_id>R01 HL109031</funding_grant_id><funding_grant_id>P50 DA019706</funding_grant_id><funding_grant_id>UL1 RR025011</funding_grant_id><pubmed_authors>Baker TB</pubmed_authors><pubmed_authors>Johnson HM</pubmed_authors><pubmed_authors>Fiore MC</pubmed_authors><pubmed_authors>Piper ME</pubmed_authors><pubmed_authors>Stein JH</pubmed_authors></additional><is_claimable>false</is_claimable><name>Effects of smoking and cessation on subclinical arterial disease: a substudy of a randomized controlled trial.</name><description>&lt;h4>Background&lt;/h4>The mechanisms by which smoking cessation reduces cardiovascular disease risk are unclear. We evaluated longitudinal changes in carotid intima-media thickness among current smokers enrolled in a prospective, randomized smoking cessation clinical trial.&lt;h4>Methodology/principal findings&lt;/h4>Subjects were enrolled in a randomized, double-blind, placebo-controlled trial of 5 smoking cessation pharmacotherapies and underwent carotid ultrasonography with carotid intima-media thickness measurement. Subjects were classified as continuously abstinent (biochemically confirmed abstinence at 6 months, 1 year, and 3 years post-quit attempt), intermittently abstinent (reported smoking at one of the three time points), or smoked continuously (reported smoking at all three time points)</description><dates><release>2012-01-01T00:00:00Z</release><publication>2012</publication><modification>2026-05-04T17:50:52.123Z</modification><creation>2019-03-26T23:18:33Z</creation></dates><accession>S-EPMC3322167</accession><cross_references><pubmed>22496918</pubmed><doi>10.1371/journal.pone.0035332</doi></cross_references></HashMap>